Company Description
Microvast Holdings, Inc. engages in the design, development, and manufacturing of battery components and systems primarily for electric commercial vehicles and energy storage systems.
The company offers a range of cell chemistries, such as lithium titanate oxide, lithium iron phosphate, electrolyte formulation, full concentration gradient cathode, polyaramid separator, and nickel manganese cobalt.
It also designs, develops, and manufactures components of lithium-ion batteries, such as cathode, anode, electrolytes, and separator.
The company’s commercial vehicle markets cover buses, trains, mining trucks, marine and port vehicles, and automated guided and specialty vehicles, as well as light, medium, and heavy-duty trucks.
It operates in China, India, rest of the Asia Pacific, Italy, France, rest of Europe, and the United States.
Microvast Holdings, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.
| Country | United States |
| Founded | 2006 |
| Industry | Auto Parts |
| Sector | Consumer Discretionary |
| Employees | 1,921 |
| CEO | Yang Wu |
Contact Details
Address: 12603 Southwest Freeway, Suite 300 Stafford, Texas 77477 United States | |
| Phone | 281 491 9505 |
| Website | microvast.com |
Stock Details
| Ticker Symbol | MVST |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1760689 |
| CUSIP Number | 59516C106 |
| ISIN Number | US59516C1062 |
| Employer ID | 83-2530757 |
| SIC Code | 3690 |
Key Executives
| Name | Position |
|---|---|
| Yang Wu | Founder, Chairman and Chief Executive Officer |
| Isida Tushe | President, General Counsel, Corporate Secretary and Director |
| Dr. Shengxian Wu Ph.D. | Chief Operating Officer |
| Rodney Worthen | Chief Financial Officer |
| Eric Garcia | Chief Accounting Officer |
| Dr. Wenjuan Mattis Ph.D. | Chief Technology Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 16, 2026 | 10-K | Annual Report |
| Mar 16, 2026 | 8-K | Current Report |
| Feb 13, 2026 | SCHEDULE 13G/A | Filing |
| Jan 9, 2026 | 8-K | Current Report |
| Dec 31, 2025 | 144 | Filing |
| Nov 10, 2025 | 8-K | Current Report |
| Nov 10, 2025 | 10-Q | Quarterly Report |
| Oct 28, 2025 | 8-K | Current Report |
| Oct 3, 2025 | 424B5 | Filing |
| Oct 3, 2025 | 8-K | Current Report |